16:01 Thu 05 Mar 2020
Grant of Restricted Stock Units and PDMR Dealings
The RADSUs have been granted to
The number of RADSUs granted has been calculated on the basis of the closing price of £0.55 of the Company’s ordinary shares (“Ordinary Shares”) quoted on AIM on
The grants will vest in four equal installments at the end of each quarter during 2020, subject to continued employment by the recipient. When fully vested,
PDMR Dealings
The notification of dealing form in respect of the RADSU awards for each PDMR can be found below.
For further information, please contact:
Tel: +44 (0)20 3283 4200 | |
info@veronapharma.com | |
N+1 Singer (Nominated Adviser and | Tel: +44 (0)20 3283 4200 |
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Dr | |||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer | ||||
b) | Initial notification /Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | ||||||
b) | Legal Entity Identifier | 213800EVI6O6J3TIAL06 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | American Depositary Shares (“ADSs”), each representing 8 Ordinary Shares. | ||||
Identification code | ISIN Code: US9250501064 | |||||
b) | Nature of the transaction | Grant of RADSUs | ||||
c) | Price(s) and volume(s) | |||||
Price(s) | Volume(s) | |||||
No consideration paid | 89,099 RADSUs (representing 712,792 Ordinary Shares) | |||||
d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) | ||||
e) | Date of the transaction | |||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | ||||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Financial Officer | ||||
b) | Initial notification /Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | ||||||
b) | Legal Entity Identifier | 213800EVI6O6J3TIAL06 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument | American Depositary Shares (“ADSs”), representing 8 Ordinary Shares. | ||||
Identification code | ISIN Code: US9250501064 | |||||
b) | Nature of the transaction | Grant of RADSUs, each of which represents an unfunded, unsecured right to receive, on the applicable settlement date, one ADS or an amount in cash or other consideration. | ||||
c) | Price(s) and volume(s) | |||||
Price(s) | Volume(s) | |||||
No consideration paid | 44,549 RADSUs (representing 356,392 Ordinary Shares) | |||||
d) | Aggregated information - Aggregated volume - Price | N/A (single transaction) | ||||
e) | Date of the transaction | |||||
f) | Place of the transaction | Outside a trading venue | ||||
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE